Saudi German Hospital’s profit declines 29% in H1

08/08/2018 Argaam Exclusive

View other reports

Share Price

Middle East Healthcare Co. (SAUDI GERMAN HEALTH)

Middle East Healthcare Co. (MEAHCO), operator of Saudi German Hospital, reported a net profit of SAR 121.4 million in the first half of 2018, a 29.4 percent year-on-year (YoY) decrease attributed to lower revenue, higher caregivers’ salaries and increased cost of suppliers.

Financials (M)

Item	6m 2017	6m 2018	Change‬
Revenues	744.81	741.24	(0.5 %)
Gross Income	319.09	277.33	(13.1 %)
Operating Income	166.00	117.48	(29.2 %)
Net Income	171.92	121.40	(29.4 %)
Average Shares	92.04	92.04	-
EPS (Riyals)	1.87	1.32	(29.4 %)

The company’s net profit for the second quarter declined by 44.7 percent YoY to SAR 34.3 million due to higher general administrative expenses, in addition to the initial operational cost of the Beverly clinics which started operation in Q1.

When compared to the previous quarter, Q2 2017 net profit dropped 60.7 percent.

Current Quarter Comparison (M)

Compared With The

Item	Q2 2017	Q2 2018	Change‬
Revenues	351.28	346.13	(1.5 %)
Gross Income	138.63	116.91	(15.7 %)
Operating Income	58.97	31.66	(46.3 %)
Net Income	61.95	34.27	(44.7 %)
Average Shares	92.04	92.04	-
EPS (Riyals)	0.67	0.37	(44.7 %)

Item	Q1 2018	Q2 2018	Change‬
Revenues	395.11	346.13	(12.4 %)
Gross Income	160.42	116.91	(27.1 %)
Operating Income	85.82	31.66	(63.1 %)
Net Income	87.13	34.27	(60.7 %)
Average Shares	92.04	92.04	-
EPS (Riyals)	0.95	0.37	(60.7 %)

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Net Income	Change	EPS(Riyal)
Q1 2009	-	-	-	-	-	-	-
Q2 2009	-	-	-	-	-	-	-
Q3 2009	-	-	-	-	-	-	-
Q4 2009	-	-	-	-	-	-	-
2009	-	-	-	-	-	-	-
Q1 2010	-	-	-	-	-	-	-
Q2 2010	-	-	-	-	-	-	-
Q3 2010	-	-	-	-	-	-	-
Q4 2010	-	-	-	-	-	-	-
2010	-	-	-	-	-	-	-
Q1 2011	-	-	-	-	-	-	-
Q2 2011	-	-	-	-	-	-	-
Q3 2011	-	-	-	-	-	-	-
Q4 2011	-	-	-	-	-	-	-
2011	436.84	-	159.99	-	36.01	-	0.39
Q1 2012	-	-	-	-	-	-	-
Q2 2012	-	-	-	-	-	-	-
Q3 2012	-	-	-	-	-	-	-
Q4 2012	-	-	-	-	-	-	-
2012	542.22	24.1 %	248.36	55.2 %	61.99	72.2 %	0.67
Q1 2013	-	-	-	-	-	-	-
Q2 2013	-	-	-	-	-	-	-
Q3 2013	-	-	-	-	-	-	-
Q4 2013	-	-	-	-	-	-	-
2013	828.36	52.8 %	430.49	73.3 %	137.20	121.3 %	1.49
Q1 2014	359.18	-	199.49	-	80.16	-	0.87
Q2 2014	347.08	-	185.78	-	92.80	-	1.01
Q3 2014	323.16	-	174.49	-	74.36	-	0.81
Q4 2014	369.34	-	190.01	-	84.64	-	0.92
2014	1,398.75	68.9 %	749.76	74.2 %	331.97	142.0 %	3.61
Q1 2015	391.64	9.0 %	208.99	4.8 %	105.39	31.5 %	1.15
Q2 2015	372.00	7.2 %	203.88	9.7 %	91.79	(1.1 %)	1.00
Q3 2015	352.20	9.0 %	183.23	5.0 %	90.75	22.0 %	0.99
Q4 2015	418.69	13.4 %	214.04	12.6 %	102.32	20.9 %	1.11
2015	1,534.53	9.7 %	810.13	8.1 %	390.25	17.6 %	4.24
Q1 2016	421.52	7.6 %	216.62	3.7 %	104.20	(1.1 %)	1.13
Q2 2016	410.07	10.2 %	212.49	4.2 %	74.07	(19.3 %)	0.80
Q3 2016	379.09	7.6 %	199.40	8.8 %	99.64	9.8 %	1.08
Q4 2016	404.96	(3.3 %)	199.88	(6.6 %)	84.73	(17.2 %)	0.92
2016	1,615.64	5.3 %	828.39	2.3 %	362.64	(7.1 %)	3.94
Q1 2017	393.53	(6.6 %)	180.47	(16.7 %)	109.97	5.5 %	1.19
Q2 2017	351.28	(14.3 %)	138.63	(34.8 %)	61.95	(16.4 %)	0.67
Q3 2017	352.98	(6.9 %)	133.30	(33.1 %)	64.88	(34.9 %)	0.70
Q4 2017	364.60	(10.0 %)	145.47	(27.2 %)	82.69	(2.4 %)	0.90
2017	1,462.39	(9.5 %)	597.87	(27.8 %)	319.49	(11.9 %)	3.47
Q1 2018	395.11	0.4 %	160.42	(11.1 %)	87.13	(20.8 %)	0.95
Q2 2018	346.13	(1.5 %)	116.91	(15.7 %)	34.27	(44.7 %)	0.37

Period	Revenues	Change	Gross Income	Change	Net Income	Change	EPS(Riyal)
2008	-	-	-	-	-	-	-
2009	-	-	-	-	-	-	-
2010	-	-	-	-	-	-	-
2011	436.84	-	159.99	-	36.01	-	0.39
2012	542.22	24.1 %	248.36	55.2 %	61.99	72.2 %	0.67
2013	828.36	52.8 %	430.49	73.3 %	137.20	121.3 %	1.49
2014	1,398.75	68.9 %	749.76	74.2 %	331.97	142.0 %	3.61
2015	1,534.53	9.7 %	810.13	8.1 %	390.25	17.6 %	4.24
2016	1,615.64	5.3 %	828.39	2.3 %	362.64	(7.1 %)	3.94
2017	1,462.39	(9.5 %)	597.87	(27.8 %)	319.49	(11.9 %)	3.47

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2009	-	-	-
Q2 2009	-	-	-
Q3 2009	-	-	-
Q4 2009	-	-	-
2009	-	-	-
Q1 2010	-	-	-
Q2 2010	-	-	-
Q3 2010	-	-	-
Q4 2010	-	-	-
2010	-	-	-
Q1 2011	-	-	-
Q2 2011	-	-	-
Q3 2011	-	-	-
Q4 2011	-	-	-
2011	36.62 %	20.91 %	8.24 %
Q1 2012	-	-	-
Q2 2012	-	-	-
Q3 2012	-	-	-
Q4 2012	-	-	-
2012	45.80 %	20.53 %	11.43 %
Q1 2013	-	-	-
Q2 2013	-	-	-
Q3 2013	-	-	-
Q4 2013	-	-	-
2013	51.97 %	21.68 %	16.56 %
Q1 2014	-	-	-
Q2 2014	-	-	-
Q3 2014	-	-	-
Q4 2014	53.60 %	25.57 %	23.73 %
2014	53.60 %	25.57 %	23.73 %
Q1 2015	53.05 %	27.10 %	24.96 %
Q2 2015	53.39 %	26.84 %	24.46 %
Q3 2015	52.93 %	27.56 %	25.09 %
Q4 2015	52.79 %	28.05 %	25.43 %
2015	52.79 %	28.05 %	25.43 %
Q1 2016	52.27 %	27.77 %	24.87 %
Q2 2016	51.57 %	26.50 %	23.17 %
Q3 2016	51.71 %	26.41 %	23.34 %
Q4 2016	51.27 %	26.12 %	22.45 %
2016	51.27 %	26.12 %	22.45 %
Q1 2017	49.90 %	26.91 %	23.20 %
Q2 2017	46.99 %	27.02 %	23.30 %
Q3 2017	43.41 %	25.39 %	21.40 %
Q4 2017	40.88 %	25.40 %	21.85 %
2017	40.88 %	25.40 %	21.85 %
Q1 2018	39.47 %	24.17 %	20.26 %
Q2 2018	38.12 %	22.54 %	18.44 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2008	-	-	-
2009	-	-	-
2010	-	-	-
2011	36.62 %	20.91 %	8.24 %
2012	45.80 %	20.53 %	11.43 %
2013	51.97 %	21.68 %	16.56 %
2014	53.60 %	25.57 %	23.73 %
2015	52.79 %	28.05 %	25.43 %
2016	51.27 %	26.12 %	22.45 %
2017	40.88 %	25.40 %	21.85 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2009	-	-	-
Q2 2009	-	-	-
Q3 2009	-	-	-
Q4 2009	-	-	-
Q1 2010	-	-	-
Q2 2010	-	-	-
Q3 2010	-	-	-
Q4 2010	-	-	-
Q1 2011	-	-	-
Q2 2011	-	-	-
Q3 2011	-	-	-
Q4 2011	-	-	-
Q1 2012	-	-	-
Q2 2012	-	-	-
Q3 2012	-	-	-
Q4 2012	-	-	-
Q1 2013	-	-	-
Q2 2013	-	-	-
Q3 2013	-	-	-
Q4 2013	-	-	-
Q1 2014	55.54 %	23.76 %	22.32 %
Q2 2014	53.53 %	28.54 %	26.74 %
Q3 2014	54.00 %	25.72 %	23.01 %
Q4 2014	51.45 %	24.43 %	22.92 %
Q1 2015	53.36 %	29.47 %	26.91 %
Q2 2015	54.81 %	27.44 %	24.67 %
Q3 2015	52.02 %	28.83 %	25.77 %
Q4 2015	51.12 %	26.62 %	24.44 %
Q1 2016	51.39 %	28.30 %	24.72 %
Q2 2016	51.82 %	22.50 %	18.06 %
Q3 2016	52.60 %	28.28 %	26.29 %
Q4 2016	49.36 %	25.48 %	20.92 %
Q1 2017	45.86 %	31.64 %	27.94 %
Q2 2017	39.46 %	22.25 %	17.64 %
Q3 2017	37.76 %	21.46 %	18.38 %
Q4 2017	39.90 %	25.53 %	22.68 %
Q1 2018	40.60 %	27.04 %	22.05 %
Q2 2018	33.78 %	15.35 %	9.90 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2009	-	-	-	-
Q2 2009	-	-	-	-
Q3 2009	-	-	-	-
Q4 2009	-	-	-	-
Q1 2010	-	-	-	-
Q2 2010	-	-	-	-
Q3 2010	-	-	-	-
Q4 2010	-	-	-	-
Q1 2011	-	-	-	-
Q2 2011	-	-	-	-
Q3 2011	-	-	-	-
Q4 2011	-	-	-	-
Q1 2012	-	-	-	-
Q2 2012	-	-	-	-
Q3 2012	-	-	-	-
Q4 2012	-	-	-	-
Q1 2013	-	-	-	-
Q2 2013	-	-	-	-
Q3 2013	-	-	-	-
Q4 2013	-	-	-	-
Q1 2014	92.04	-	-	10.70
Q2 2014	92.04	-	-	11.69
Q3 2014	92.04	-	-	12.48
Q4 2014	92.04	3.61	3.61	12.38
Q1 2015	92.04	3.88	3.88	13.50
Q2 2015	92.04	3.87	3.87	12.67
Q3 2015	92.04	4.05	4.05	13.63
Q4 2015	92.04	4.24	4.24	14.70
Q1 2016	92.04	4.23	4.23	16.39
Q2 2016	92.04	4.03	4.03	15.20
Q3 2016	92.04	4.13	4.13	16.43
Q4 2016	92.04	3.94	3.94	17.32
Q1 2017	92.04	4.00	4.00	18.46
Q2 2017	92.04	3.87	3.87	17.09
Q3 2017	92.04	3.49	3.49	17.74
Q4 2017	92.04	3.47	3.47	15.75
Q1 2018	92.04	3.22	3.22	16.69
Q2 2018	92.04	2.92	2.92	15.07

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2008	-	-	-	-
2009	-	-	-	-
2010	-	-	-	-
2011	92.04	0.39	0.39	6.03
2012	92.04	0.67	0.67	6.65
2013	92.04	1.49	1.49	9.84
2014	92.04	3.61	3.61	12.38
2015	92.04	4.24	4.24	14.70
2016	92.04	3.94	3.94	17.32
2017	92.04	3.47	3.47	15.75

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2009	-	-	-
Q2 2009	-	-	-
Q3 2009	-	-	-
Q4 2009	-	-	-
Q1 2010	-	-	-
Q2 2010	-	-	-
Q3 2010	-	-	-
Q4 2010	-	-	-
Q1 2011	-	-	-
Q2 2011	-	-	-
Q3 2011	-	-	-
Q4 2011	-	-	-
Q1 2012	-	-	-
Q2 2012	-	-	-
Q3 2012	-	-	-
Q4 2012	-	-	-
Q1 2013	-	-	-
Q2 2013	-	-	-
Q3 2013	-	-	-
Q4 2013	-	-	-
Q1 2014	-	-	-
Q2 2014	-	-	-
Q3 2014	-	-	-
Q4 2014	-	-	-
Q1 2015	-	-	-
Q2 2015	-	-	-
Q3 2015	-	-	-
Q4 2015	-	-	-
Q1 2016	17.17	17.17	4.43
Q2 2016	17.16	17.16	4.56
Q3 2016	12.41	12.41	3.12
Q4 2016	18.62	18.62	4.23
Q1 2017	18.48	18.48	4.01
Q2 2017	19.45	19.45	4.41
Q3 2017	17.98	17.98	3.54
Q4 2017	15.52	15.52	3.42
Q1 2018	17.90	17.90	3.46
Q2 2018	20.02	20.02	3.88

Period	P/E	Adjusted P/E	Price/book
2008	-	-	-
2009	-	-	-
2010	-	-	-
2011	-	-	-
2012	-	-	-
2013	-	-	-
2014	-	-	-
2015	-	-	-
2016	18.62	18.62	4.23
2017	15.52	15.52	3.42

Business Segments (Million)

Compared With The

Period	Inpatient clinics	Outpatient clinics	Pharmacy Sales	Others
Q1 2014	207.07	85.01	64.94	2.16
Q2 2014	200.50	77.40	66.66	2.51
Q1 2015	224.99	91.95	70.24	4.46
Q2 2015	211.41	86.64	70.30	3.65
Q3 2015	200.38	85.53	63.54	2.76
Q4 2015	220.47	119.55	72.94	5.72
Q1 2016	241.22	100.20	73.04	7.06
Q2 2016	229.99	99.85	72.93	7.31
Q3 2016	224.32	89.88	62.16	2.72
Q4 2016	220.91	107.73	72.64	3.69
Q1 2017	242.80	104.89	71.94	4.27
Q2 2017	224.48	92.89	70.77	3.54
Q3 2017	133.39	85.39	60.16	3.27
Q4 2017	172.44	114.51	71.35	6.30
Q1 2018	214.32	109.10	68.50	3.20
Q2 2018	188.62	79.63	76.10	1.78

Period	Inpatient clinics	Outpatient clinics	Pharmacy Sales	Others
2013	-	-	159.08	1.19
2014	807.92	323.31	257.32	10.20
2015	857.25	383.67	277.02	16.59
2016	916.44	397.66	280.76	20.77
2017	773.12	397.68	274.21	17.38

Analysts Estimates (Million)

Item	Q2 2018 (e)	Q2 2018 (a)	Change‬
Average	73.92	34.27	(53.6 %)

Estimates vs Actual (Million)

Item	Q2 2018 (e)	Q2 2018 (a)	Change
AlJazira Capital	66.50	34.27	(48.5) %
OSOOL AND BAKHEET	68.60	34.27	(50.0) %
Sico	70.00	34.27	(51.0) %
Arbah Capital	81.50	34.27	(57.9) %
SNB Capital	83.00	34.27	(58.7) %

Financial Ratios

	Current
Market Cap (M Riyal)	7,593.30
Enterprise Value (EV) (M)	9,928.87
Shares Outstanding ((M))	92.04
EPS ( Riyal) (TTM)	1.98
Book Value (BV) ( Riyal)	17.08
Par Value ( Riyal)	10.00
Adjusted P/E (Last12)	41.72
P/E (TTM)	41.72
Price/book	4.83
Return on Average Assets (%) (TTM)	3.8
Return on Average Equity (%) (TTM)	12.2

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Sign In

Search Result

Saudi German Hospital’s profit declines 29% in H1

View other reports

Share Price

Middle East Healthcare Co. (SAUDI GERMAN HEALTH)

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2018 Q2

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Sign In

×

Forgot password?

Saudi German Hospital’s profit declines 29% in H1

View other reports

Share Price

Middle East Healthcare Co. (SAUDI GERMAN HEALTH)

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q2 2018

Revenue by Business Segment (Latest) 2018 Q2

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)